Clinical neuroscience of addiction: similarities and differences between alcohol and other drugs.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Alcoholism: Clinical and Experimental Research

• Publication date

  2015-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/acer.12884PMID 26414497
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Understanding opioid reward.

  2015cited by this paper
• Gabapentin in Alcohol Dependence

  2015cited by this paper
• Topiramate for smoking cessation: a randomized, placebo-controlled pilot study.

  2014cited by this paper
• Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism.

  2014cited by this paper
• Neuroimmune mechanisms of alcohol and drug addiction.

  2014cited by this paper
• DAT isn’t all that: cocaine reward and reinforcement requires Toll Like Receptor 4 signaling

  2014cited by this paper
• Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial.

  2014cited by this paper
• Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.

  2014cited by this paper
• Gabapentin treatment for alcohol dependence: a randomized clinical trial.

  2014cited by this paper
• Review: In alcohol use disorders, oral naltrexone, 50 mg/d, or acamprosate reduces return to drinking

  2014cited by this paper
• Low-Dose Topiramate in Alcohol Dependence: A Single-Blind, Placebo-Controlled Study

  2014cited by this paper
• Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial.

  2014cited by this paper
• A meta-analysis of topiramate's effects for individuals with alcohol use disorders.

  2014cited by this paper
• Glial modulators as potential treatments of psychostimulant abuse.

  2014cited by this paper
• Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues.

  2014cited by this paper
• Neural correlates of substance abuse: Reduced functional connectivity between areas underlying reward and cognitive control

  2014cited by this paper
• Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence.

  2014cited by this paper
• Treatment of crack-cocaine dependence with topiramate: a randomized controlled feasibility trial in The Netherlands.

  2014cited by this paper
• Reduced left executive control network functional connectivity is associated with alcohol use disorders.

  2014cited by this paper
• The role of the opioid system in alcohol dependence

  2014cited by this paper
• Topiramate Treatment of Heavy Drinkers: Moderation by a GRIK1 Polymorphism

  2014cited by this paper
• Separate and combined effects of gabapentin and Δ9-THC doses in cannabis users discriminating Δ9-THC

  2014cited by this paper
• A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence.

  2013cited by this paper
• Transcranial Doppler sonography for detecting stenosis or occlusion of intracranial arteries in people with acute ischaemic stroke

  2013cited by this paper
• Meta-analysis of structural brain abnormalities associated with stimulant drug dependence and neuroimaging of addiction vulnerability and resilience.

  2013cited by this paper
• Assessing Cue-Induced Brain Response as a Function of Abstinence Duration in Heroin-Dependent Individuals: An Event-Related fMRI Study

  2013cited by this paper
• Role of amygdala in drug memory.

  2013cited by this paper
• Review: Microglia of the aged brain: primed to be activated and resistant to regulation

  2013cited by this paper
• Substance use disorders: a theory‐driven approach to the integration of genetics and neuroimaging

  2013cited by this paper
• Cellular basis of memory for addiction

  2013cited by this paper
• Neuroimmune signaling: a key component of alcohol abuse.

  2013cited by this paper
• Glutamatergic targets for new alcohol medications

  2013cited by this paper
• Topiramate for the treatment of cocaine addiction: a randomized clinical trial.

  2013cited by this paper
• Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta‐analysis and systematic review

  2013cited by this paper
• Fronto‐striatal functional connectivity during response inhibition in alcohol dependence

  2013cited by this paper
• Efficacy of interventions to combat tobacco addiction: Cochrane update of 2012 reviews.

  2013cited by this paper
• Methadone at tapered doses for the management of opioid withdrawal.

  2013cited by this paper
• A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence

  2013cited by this paper
• Opioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement

  2012cited by this paper
• Effects of Naltrexone on Smoking Cessation Outcomes and Weight Gain in Nicotine-Dependent Men and Women

  2012cited by this paper
• Substance Use Predictors of Poor Medication Adherence: The Role of Substance Use Coping Among HIV-Infected Patients in Opioid Dependence Treatment

  2012cited by this paper
• Results of an initial clinical trial of varenicline for the treatment of cocaine dependence.

  2012cited by this paper
• Repurposing approved and abandoned drugs for the treatment and prevention of cancer through public-private partnership.

  2012cited by this paper
• A Proof-of-Concept Randomized Controlled Study of Gabapentin: Effects on Cannabis Use, Withdrawal and Executive Function Deficits in Cannabis-Dependent Adults

  2012cited by this paper
• Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence.

  2012cited by this paper
• Immune system inflammation in cocaine dependent individuals: implications for medications development

  2012cited by this paper
• Varenicline decreases alcohol consumption in heavy-drinking smokers

  2012cited by this paper
• The neurobiology of opiate motivation.

  2012cited by this paper
• Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial.

  2012cited by this paper
• NADPH oxidase and reactive oxygen species contribute to alcohol-induced microglial activation and neurodegeneration

  2012cited by this paper
• Epidemiology of substance use disorders

  2012cited by this paper
• Nicotine replacement therapy for smoking cessation.

  2012cited by this paper
• "Liking" and "wanting" linked to Reward Deficiency Syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry.

  2012cited by this paper
• Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications

  2011cited by this paper
• Gabapentin combined with naltrexone for the treatment of alcohol dependence.

  2011cited by this paper
• Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study

  2011cited by this paper
• Reengineering Translational Science: The Time Is Right

  2011cited by this paper
• Neuronal Mechanisms Underlying Development of Nicotine Dependence: Implications for Novel Smoking-Cessation Treatments

  2011cited by this paper
• Microglia in neurodegenerative disease

  2010cited by this paper
• Topiramate in the treatment of substance-related disorders: a critical review of the literature.

  2010cited by this paper
• Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients.

  2010cited by this paper
• Altered neural response of the appetitive emotional system in cocaine addiction: an fMRI Study

  2010cited by this paper
• Neurocircuitry of Addiction

  2010cited by this paper
• Gabapentin for smoking cessation.

  2010cited by this paper
• Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial.

  2010cited by this paper
• Activation of α4* nAChRs is Necessary and Sufficient for Varenicline-Induced Reduction of Alcohol Consumption

  2010cited by this paper
• Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study

  2010cited by this paper
• Efficacy of a Combination of Flumazenil and Gabapentin in the Treatment of Alcohol Dependence: Relationship to Alcohol Withdrawal Symptoms

  2009cited by this paper
• Mechanisms of neurodegeneration and regeneration in alcoholism.

  2009cited by this paper
• Altered Sensitivity to Rewarding and Aversive Drugs in Mice with Inducible Disruption of cAMP Response Element-Binding Protein Function within the Nucleus Accumbens

  2009cited by this paper
• Frontal and cingulate gray matter volume reduction in heroin dependence: Optimized voxel‐based morphometry

  2009cited by this paper
• Varenicline reduces alcohol self-administration in heavy-drinking smokers.

  2009cited by this paper
• Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

  2009cited by this paper
• The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia.

  2009cited by this paper
• Proof‐of‐concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin

  2009cited by this paper
• Varenicline: a first-line treatment option for smoking cessation.

  2009cited by this paper
• Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial.

  2008cited by this paper
• Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study.

  2008cited by this paper
• Increased MCP-1 and microglia in various regions of the human alcoholic brain.

  2008cited by this paper
• Neurobiology of Alcohol Dependence

  2008cited by this paper
• Impaired response inhibition function in abstinent heroin dependents: an fMRI study.

  2008cited by this paper
• Bupropion for the Treatment of Methamphetamine Dependence

  2008cited by this paper
• The Role of Oxidative Stress, Metabolic Compromise, and Inflammation in Neuronal Injury Produced by Amphetamine-Related Drugs of Abuse

  2008cited by this paper
• Bupropion Hydrochloride versus Placebo, in Combination with Cognitive Behavioral Therapy, for the Treatment of Cocaine Abuse/Dependence

  2008cited by this paper
• Treating Tobacco Use and Dependence: 2008 Update U.S. Public Health Service Clinical Practice Guideline Executive Summary

  2008cited by this paper
• A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia.

  2008cited by this paper
• Comparing topiramate with naltrexone in the treatment of alcohol dependence.

  2008cited by this paper
• Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation.

  2008cited by this paper
• Using topiramate or naltrexone for the treatment of alcohol-dependent patients.

  2008cited by this paper
• Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial.

  2008cited by this paper
• Alcohol Detoxification and Relapse Prevention Using Valproic Acid Versus Gabapentin in Alcohol-dependent Patients

  2008cited by this paper
• Amygdala volume associated with alcohol abuse relapse and craving.

  2008cited by this paper
• Gabapentin for smoking cessation: a preliminary investigation of efficacy.

  2007cited by this paper
• Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam.

  2007cited by this paper
• Topiramate for treating alcohol dependence: a randomized controlled trial.

  2007cited by this paper
• Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.

  2007cited by this paper
• Limbic Activation to Cigarette Smoking Cues Independent of Nicotine Withdrawal: A Perfusion fMRI Study

  2007cited by this paper
• Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial.

  2007cited by this paper
• Effects of acute topiramate dosing on methamphetamine-induced subjective mood.

  2007cited by this paper
• Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients.

  2007cited by this paper

• Effect of EEG neurofeedback therapy on addiction disorders: A systematic review and meta-analysis.

  2025cites this paper
• The efficacy of conventional and technology assisted cue exposure therapy for treating substance use disorders: a qualitative systematic review

  2025cites this paper
• The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials

  2025cites this paper
• Towards virtual reality exposure therapy for cocaine use disorder: A feasibility study of inducing cocaine craving through virtual reality

  2024cites this paper
• Criminal behaviors and substance use disorder in psychiatric patients

  2024cites this paper
• A Review of Functional Brain Differences Predicting Relapse in Substance Use Disorder: Actionable Targets for New Methods of Noninvasive Brain Stimulation.

  2022cites this paper
• Effects of Medication-Assisted Treatment (MAT) for Opioid Use Disorder on Functional Outcomes: A Systematic Review.

  2020cites this paper
• Adult ADHD in Substance-Related and Addictive Disorders

  2020cites this paper
• Current Evidence on Abuse and Misuse of Gabapentinoids

  2020cites this paper
• Sex differences in the effect of bupropion and naltrexone combination on alcohol drinking in mice.

  2019cites this paper
• G protein-coupled receptor heteromers are key players in substance use disorder.

  2019cites this paper
• Frustration Tolerance and Personality Traits in Patients With Substance Use Disorders

  2019cites this paper
• Neural Correlates of Polysubstance Use: Differential and Interactive Effects of Alcohol and Cannabis on the Adolescent Brain

  2018cites this paper
• Involvement of Activated Brain Stress Responsive Systems in Excessive and “Relapse” Alcohol Drinking in Rodent Models: Implications for Therapeutics

  2018cites this paper
• Do Alcohol-Related AMPA-Type Glutamate Receptor Adaptations Promote Intake?

  2018cites this paper
• Can deep transcranial magnetic stimulation (DTMS) be used to treat substance use disorders (SUD)? A systematic review

  2018influential citation
• How addictive are gabapentin and pregabalin? A systematic review.

  2017influential citation
• Daily Stressors as Antecedents, Correlates, and Consequences of Alcohol and Drug Use and Cravings in Community-Based Offenders

  2017cites this paper
• Opioid tapering in patients with prescription opioid use disorder: A retrospective study

  2017cites this paper
• Treatment of alcohol use disorder and co-occurring PTSD

  2017cites this paper
• Neurobiological Evidence in Alcohol Addiction Can Help Pharmacological Treatment Personalization

  2016cites this paper
• A Call to Integrate Neuroscience and Translational Research in Psychopathology: A literature review of the RDoC and substance abuse disorder

  2016cites this paper
• Neurophysiological, psychological and behavioural correlates of rTMS treatment in alcohol dependence.

  2016cites this paper